ACB earnings

NASDAQ | TSX: ACBEDMONTON, AB, May 28, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2026 on Thursday, June 11, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter and fiscal year 2026 before the opening of markets that same day. Conference Call DetailsDATE:Thursday, June 11, 2026TIME:8:00 a.m. Eastern Time | 6:00 a.m. Mountain TimeWEBCAST:

NASDAQ | TSX: ACB Expands YoY Total Net Revenue1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue1 Increasing by 12% to a Record $76.2 millionDelivers Adjusted EBITDA1 of $18.5 million and Adjusted Net Income1 of $7.2 millionGenerates Free Cash Flow1 of $15.5 million Maintains Strong Balance Sheet with $154.4 million of Cash2 and Short-Term Investments, and a Debt-Free Cannabis Business2EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter 2026 period ending December 31, 2025.

NASDAQ | TSX: ACB EDMONTON, AB, Jan. 21, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2026 on Wednesday, February 4, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the third quarter 2026 before the opening of markets that same day. Conference Call Details DATE: Wednesday, February 4, 2026 TIME: 8:00 a.m. Eastern Time |

Expands YoY Global Medical Cannabis Net Revenue1 by 15% to Record $70.5 millionIncreases International Medical Cannabis Net Revenue1 by 22% to Record $42.7 million, with leadership positions across key marketsDelivers Adjusted EBITDA1 growth of 52%, reaching $15.4 million  Maintains Strong Balance Sheet with $141.9 million of Cash and Debt-Free Cannabis Business2NASDAQ | TSX: ACB EDMONTON, AB, Nov. 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter 2026 period ending September 30, 2025.

NASDAQ | TSX: ACB EDMONTON, AB, Oct. 22, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its second quarter 2026 on Wednesday, November 5, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the second quarter 2026 before the opening of markets that same day. Conference Call Details DATE: Wednesday, November 5, 2025 TIME: 8:00 a.m. Easte

Canada's Largest Medical Cannabis Company to Discuss Strategy, Industry Trends, and Long-Term Growth Outlook EDMONTON, ALBERTA, Aug. 7, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, will participate in Canaccord Genuity 45th Annual Growth Conference in Boston, MA. Simona King, Chief Financial Officer at Aurora, will take part in a fireside chat on August 13th at 1:30pm EST and conduct one-on-one meetings with investors throughout the day. The discussion will cover Aurora's strategic direction, recen

NASDAQ | TSX: ACB Expands YoY Global Medical Cannabis Net Revenue1 by 37% to $64.8 million, while increasing International Medical Cannabis Net Revenue1 by 85% to $37.1 millionDelivers Adjusted EBITDA1 growth in excess of 200%, reaching $10.8 million Generates Positive Free Cash Flow1 of $9.2 million, representing significant YoY growth of 42% Maintains Strong Balance Sheet with ~$186.0 million of Cash and Debt-Free Cannabis Business2EDMONTON, AB, Aug. 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the first quarter 2026 period end

      NASDAQ | TSX: ACB EDMONTON, AB, July 23, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2026 on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the first quarter 2026 before the opening of markets that same day. Conference Call Details DATE: Wednesday, August 6, 2025 TIME: 8:00 a.m. Easte

 NASDAQ | TSX: ACB Achieves Record Annual Global Medical Cannabis Net Revenue1 of $244.4 million, representing 39% YoY growthDelivers Record Adjusted EBITDA1 of $49.7 million, representing 261% YoY growthGenerates Annual Positive Free Cash Flow1 of $9.9 million Sustains Strong Balance Sheet with ~$185.3 million of Cash and Debt-Free Cannabis Business2EDMONTON, AB, June 18, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the fourth quarter and fiscal year 2025 periods ending March 31, 2025.

NASDAQ | TSX: ACB EDMONTON, AB, June 3, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2025 on Wednesday, June 18, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter fiscal year 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, June 18, 2025

NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company to Discuss Key Trends, Market Opportunities and the Future of the Global Cannabis Industry EDMONTON, AB, May 27, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, will participate in TD Cowen's 9th Annual Future of the Consumer Conference in New York City, NY. Simona King, Chief Financial Officer at Aurora, will take part in a fireside chat and one-on-one meetings with investors on June 3, 2025, at 2:45pm EST. Conference Call Details DATE: Tues

NASDAQ | TSX: ACB Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoYGenerates Record Net Income of $31.2 Million, up 282% YoY, and Record Adjusted EBITDA1 of $23.1 Million, up 316% YoYAchieves Target of Positive Free Cash Flow1 in Q3, Generating $27.4 Million of Free Cash Flow1Maintains Strong Balance Sheet with $180 Million of Cash and Debt-Free Cannabis Business2EDMONTON, AB, Feb. 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third qu

NASDAQ | TSX: ACB EDMONTON, AB, Jan. 22, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2025 on Wednesday, February 5, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the third quarter 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, February 5, 2025 TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time WEBCAST: Click Here Miguel Martin, Executive Chairman and Chief Executive Officer,

NASDAQ | TSX: ACB Record Adjusted EBITDA1 of $10.1 Million, a YoY increase of 210%Quarterly Net Revenue1 up 29% YoY to $81.1 Million, with 41% growth in Global Medical CannabisRe-Affirms Target of Positive Free Cash Flow1 in the Quarter Ending December 31, 2024Maintains Strong Balance Sheet with ~$152 Million of Cash and a Debt-Free Cannabis Business2EDMONTON, AB, Nov. 6, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter fiscal 2025.

NASDAQ | TSX: ACB EDMONTON, AB, Oct. 24, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today announced today that it has scheduled a conference call to discuss the results for its second quarter 2025 on Wednesday, November 6, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the second quarter 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, November 6, 2024 TIME:

Delivers Positive Free Cash Flow1 of $6.5 MillionIncreases Total Quarterly Net Revenue1 by 12% YoY to $83.4 Million, Record Net Revenue1 of $47.2 Million in Global Medical Cannabis  Generates Adjusted EBITDA1 of $4.9 Million, a YoY increase of 87%Ends the Fiscal Quarter with a Debt-Free Cannabis Business2 and a Cash Position of ~$182 Million EDMONTON, AB, Aug. 7, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the first quarter fiscal 2025.

Delivers Positive Free Cash Flow1 of $6.5 MillionIncreases Total Quarterly Net Revenue1 by 12% YoY to $83.4 Million, Record Net Revenue1 of $47.2 Million in Global Medical Cannabis  Generates Adjusted EBITDA1 of $4.9 Million, a YoY increase of 87%Ends the Fiscal Quarter with a Debt-Free Cannabis Business2 and a Cash Position of ~$182 Million EDMONTON, AB, Aug. 7, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the first quarter fiscal 2025.

NASDAQ | TSX: ACB EDMONTON, AB, July 29, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2025 on Wednesday, August 7, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the first quarter 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, August 7, 2024 TIME: 8:00 a.m. Eastern Time |

Delivers Record Annual Adjusted EBITDA1 of $12.8 Million NASDAQ | TSX: ACB Q4 Represents the Sixth Consecutive Quarter of Positive Adjusted EBITDA1Increased Total Quarterly Net Revenue 5% YoY to $67.4 Million, Global Medical Cannabis Net Revenue1 Grew by 20% YoY to $45.6 MillionEnded the Fiscal Year with a Cash Position of ~$180 Million with Cannabis Business Debt-Free2 Re-Affirms Target of Reaching Positive Free Cash Flow1 by December 31, 2024EDMONTON, AB, June 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the fourth quarter and

NASDAQ | TSX: ACB EDMONTON, AB, June 7, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2024 on Thursday, June 20, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter fiscal year 2024 before the opening of markets that same day. Conference Call Details DATE: Thursday, June 20, 2024 TIME:

                                                                                                       NASDAQ | TSX: ACB Re-Affirms Commitment to Achieving Positive Free Cash Flow1 This Calendar Year, Delivers Fifth Consecutive Quarter of Positive Adjusted EBITDA1Aurora Becomes the Largest Global Medical Cannabis Company in Nationally Legal Markets Following the Acquisition of MedReleaf Australia Strong YoY Growth of 41% in High Margin International Net Cannabis Revenue1Cash position of over $200 Million as of Quarter Close, Remaining Convertible Debt of $7.3 Million to be Fully Repaid in FebruaryEDMONTON, AB, Feb. 8, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASD

NASDAQ | TSX: ACB Re-affirms expectation of positive annual Adjusted EBITDA1 for fiscal 2024 and Positive Free Cash Flow1 generation in calendar 2024Announces Intention to Consolidate Common SharesQ3 2024 Investor Conference call scheduled for February 8, 2024 at 8:00 a.m. Eastern TimeEDMONTON, AB, Jan. 31, 2024 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, provided key business updates today and confirmed that it will release financial results and host an investor conference call for its third quarter of fiscal 2024 ended December 31, 2023, on February 8, 2024.

Achieves Quarterly Net Revenue1 of $75.1 Million; Strong YoY Growth Across All Business Units; Global Medical Cannabis +14%, Consumer Cannabis +5%, Plant Propagation +12%Delivers Third Sequential Quarter of Positive Adjusted EBITDA1, Supported by Bevo's Record Quarterly Revenue Cash Used in Operating Activities Reduced by $15.5 Million YoY, Re-Affirms Target of Positive Free Cash Flow in Calendar Year 2024NASDAQ | TSX: ACB EDMONTON, AB, Aug. 10, 2023 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company opening the world to cannabis, today announced its financial and operational results for the first quarter of fiscal year 2024. As the f

 NASDAQ| TSX: ACB EDMONTON, AB , July 27, 2023 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company opening the world to cannabis, announced today that it has scheduled a conference call to discuss the results for its first quarter fiscal year 2024 on Thursday, August 10, 2023 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for this period after the close of markets that same day. Conference Call DetailsDATE: Thursday, August 10 2023 TIME: 5:00 p.m. Eastern Time | 3:00 p.

NASDAQ |  TSX: ACB Achieves Second Sequential Quarter of Positive Adjusted EBITDA1Net Revenue Reaches $64 Million, Increasing 4% Sequentially and 27% YoY; Driving Adjusted Gross Profit1 of $30.6 MillionBalance Sheet Remains Strong With a Cash Position of ~$230 Million Cash on Hand with ~$80 Million of Convertible Notes Remaining OutstandingClear Path to Achieve Positive Free Cash Flow by the End of Calendar Year 2024 Through Additional $40 Million of Annualized Cost EfficienciesEDMONTON, AB, June 14, 2023 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company opening the world to cannabis, today announced its financial and operational results fo

NASDAQ |  TSX: ACB Achieves Second Sequential Quarter of Positive Adjusted EBITDA1Net Revenue Reaches $64 Million, Increasing 4% Sequentially and 27% YoY; Driving Adjusted Gross Profit1 of $30.6 MillionBalance Sheet Remains Strong With a Cash Position of ~$230 Million Cash on Hand with ~$80 Million of Convertible Notes Remaining OutstandingClear Path to Achieve Positive Free Cash Flow by the End of Calendar Year 2024 Through Additional $40 Million of Annualized Cost EfficienciesEDMONTON, AB, June 14, 2023 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company opening the world to cannabis, today announced its financial and operational res

NASDAQ | TSX: ACB EDMONTON, AB, June 7, 2023 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company opening the world to cannabis, announced today that it has scheduled a conference call to discuss the results for its third quarter and full fiscal year 2023 on Wednesday, June 14, 2023 at 8:15 a.m. Eastern Time | 6:15 a.m. Mountain Time. The Company will report its financial results for the third quarter and full fiscal year 2023 before the opening of markets that same day. As a reminder, Fiscal 2023 is comprised of three quarters ending March 31, 2023.

NASDAQ | TSX: ACB Cannabis Revenues Up ~20% from Fiscal Q1 2023, Net Revenue1 of $61.7 MillionAchieves Positive Adjusted EBITDA1 in Line with Prior GuidanceDelivers ~$340 Million in Annualized Cost Savings Since February 2020Balance Sheet Remains in Net Cash Position, Among Strongest in Industry; Debt Reduction of ~$302 Million in CY 2022 EDMONTON, AB, Feb. 9, 2023 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company opening the world to cannabis, today announced its financial and operational results for the fiscal second quarter ended December 31, 2022. As a reminder, Fiscal 2023 is comprised of three quarters ending March 31, 2023.

EDMONTON, AB, Jan. 26, 2023 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2023 on Thursday, February 9, 2023 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the second quarter fiscal year 2023 after the close of markets that same day. Conference Call DetailsDATE: Thursday, February 9, 2023TIME:  5:00 p.

NASDAQ | TSX: ACB EDMONTON, AB, Oct. 27, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its first quarter fiscal year 2023 on Thursday, November 10, 2022 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the first quarter fiscal year 2023 after the close of markets that same day. Conference Call DetailsDATE: Thursday, November 10,

Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Cannabis Net Revenue Increased 35.4% from Q4 2021 and 70.3% from Fiscal 2021Reiterates Adjusted EBITDA Profitability Run Rate by December 31, 2022Reaffirms $150 to $170 Million in Annualized Cost Savings by December 31, 2022Strengthens Balance Sheet Through Accretive Debt Reduction Totaling $155.3 Million in Q4 2022Completed Profitable Acquisition of Thrive Cannabis and Majority Investment in Bevo FarmsEDMONTON, AB, Sept. 20, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, today announced

                                                                                           NASDAQ | TSX: ACB EDMONTON, AB, Aug. 29, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and full fiscal year 2022 on Tuesday, September 20, 2022 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the fourth quarter and full fiscal year 2022 after the close of markets that same day.

Increasing Original Target for Expense Savings; Management Now Expects $150 to $170 Million in Annualized Cost Savings by H1/2023 versus Stated Target of $60 to $80 MillionReiterating Adjusted EBITDA Profitability Run Rate by the End of Fiscal H1 2023Remains #1 Canadian LP in High Margin Global Medical Cannabis Revenues; International Medical Revenue Increased 55% from Q3 2021Strong balance sheet; Early Repurchase of $141.4 Million in Convertible DebtEDMONTON, AB, May 12, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the

EDMONTON, AB, May 3, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its third quarter fiscal year 2022 on Thursday, May 12, 2022 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the third quarter fiscal year 2022 after the close of markets that same day. Conference Call Details DATE: Thursday, May 12, 2022 TIME: 5:00 p.m. Eastern

Global Cannabis Net Revenue of $60.6 MillionAdjusted EBITDA Improved by 22% to a loss of $9.0 Million versus Q1 2022 Company Reaffirms Goal of Adjusted EBITDA Profitability by H1/2023Transformation Plan Ahead of Schedule; Company Now Expects to Realize Upper End of $60 to $80 Million Range in Total Cost Savings by H1/2023; ~$60 Million Annualized Savings Implemented to DateCompany Remains #1 Canadian LP in Global Medical Cannabis; International Cannabis Revenue Increased 24% from Q1 2022NASDAQ | TSX: ACB EDMONTON, AB, Feb. 10, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, toda

NASDAQ | TSX: ACB EDMONTON, AB, Feb. 1, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2022 on Thursday, February 10, 2022 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the second quarter fiscal year 2022 after the close of markets that same day. Conference Call Details DATE: Thursday, February 10

Transformation Plan On Track; Actions Taken-to-Date Have Driven Over $33 Million in Annualized Run-Rate Cost Savings Total Cannabis Net Revenue, Net of Provisions, Grew ~10% to $60.1 million Compared to $54.8 Million in Q4 2021 Adjusted EBITDA Excluding Restructuring Costs Improved by $4.0 million to a loss of $11.5 million versus Q4 2021; Clear Pathway to Adjusted EBITDA Profitability by H1/FY23 Improved Adjusted Gross Margin before FVA of 54% versus 53% in Q4 2021 EDMONTON, AB, Nov. 9, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational

EDMONTON, AB, Oct. 26, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its first quarter fiscal year 2022 on Tuesday, November 9, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the first quarter fiscal year 2022 after the close of markets that same day. Conference Call Details DATE: Tuesday, November 9, 2021 TIME: 5:00 p.m.

Starting today, all Canna Cabana retail cannabis stores will transition to a discount club concept with exclusive benefits targeted to Cabana Club members. This accelerates High Tide's previously-announced entry into the value segment, and positions the Company as the largest cannabis value retailer overnight.High Tide's mature ecosystem of in-house brands and products perfectly positions the Company to become an exclusive cannabis discount club retailer and to eventually grow its Cabana Club loyalty plan into a global, membership-based cannabis community.Approximately 40% of Canadian cannabis sales are still conducted through the illicit market.1 With over 70% of Canadian cannabis consumers

Starting today, all Canna Cabana retail cannabis stores will transition to a discount club concept with exclusive benefits targeted to Cabana Club members. This accelerates High Tide's previously-announced entry into the value segment, and positions the Company as the largest cannabis value retailer overnight. High Tide's mature ecosystem of in-house brands and products perfectly positions the Company to become an exclusive cannabis discount club retailer and to eventually grow its Cabana Club loyalty plan into a global, membership-based cannabis community. Approximately 40% of Canadian cannabis sales are still conducted through the illicit market.1 With over 70% of Canadian cannabis c

NASDAQ | TSX: ACB #1 Canadian LP in Global Medical Cannabis; Total Medical Cannabis Net Revenue Rose 9% Compared to Prior Year; Strong Adjusted Gross Margin before FVA of 68% Business Transformation Plan on Track; Reiterates Annual Cost Savings of $60 Million to $80 Million, Providing Clear Pathway to Adjusted EBITDA Profitability Balance Sheet Remains Strong with $440.9 Million of Cash at June 30, 2021; Working Capital Improves by $404.3 Million Compared to Prior Year Adjusted EBITDA Loss, Excluding Restructuring Costs, Narrows to $13.9 Million, a $17.6 Million Improvement Compared to Prior Year Total Cannabis Net Revenue, Net of Provisions, of $54.8 Million Compared to $55.2 Million in the

NASDAQ | TSX: ACB EDMONTON, AB, Sept. 20, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has rescheduled its conference call to discuss the results for its fourth quarter and full fiscal year 2021 to Monday, September 27, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the fourth quarter and full fiscal year 2021, and file its related annual disclosure documents, after the close of markets that same day.

CALGARY, AB, Sept. 14, 2021 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, filed its financial results for the third fiscal quarter of 2021 ending July 31, 2021, the highlights of which are included in this news release. The full set of Condensed Interim Consolidated Financial Statements and Management's Discussion and Analysis can be viewed by visiting High Tide's website at www.hightideinc.com, its profile page on SEDAR at www.sedar.com, and its profile page on EDGAR at www.sec.com.

NASDAQ | TSX: ACB EDMONTON, AB, Sept. 7, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and full fiscal year 2021 on Tuesday, September 21, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the fourth quarter and full fiscal year 2021 after the close of markets that same day. Conference Call Details DATE:

CALGARY, AB, Aug. 25, 2021 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV:HITI) (NASDAQ:HITI) (FSE: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, announced today that the Company will release its financial and operational results for the quarter ended July 31, 2021 after market close on Tuesday, September 14, 2021. High Tide's third quarter 2021 financial and operational results will be available on SEDAR and on the Company's website at www.hightideinc.com/invest. Following the releas